Live Breaking News & Updates on Head Of Corporate Development At Abbisko Therapeutics

Stay updated with breaking news from Head of corporate development at abbisko therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development

SINGAPORE, BOSTON and SHANGHAI, June 28, 2022 /PRNewswire/ Cargene Biopharma Inc. ("Cargene", the "Company"), a biopharmaceutical company developing oligonucleotide therapeutics for liver and ophthalmic disorders, is excited to welcome Kathy He, a seasoned biopharmaceutical industry executive, to join the Company as Chief Executive Officer and a member of the board. Kathy brings over 20 years of R&D and commercial experience from multiple global companies to her new role at Cargene, notably in building differentiated product portfolios, developing strategic opportunities, and successfully bringing innovative therapeutics to market. Based in Singapore, Boston and Shanghai, Cargene Biopharma aims to leverage its novel biology and chemistry insights to develop highly specific, stable and potent nucleic acid therapeutics for a broad range of diseases. In December 2021, the Company successfully closed a pre-Series A funding round of nearly US$20 million, led by Bio ....

Kellogg School , United States , University Of Illinois , Cargene Biopharma , Head Of Corporate Development At Abbisko Therapeutics , Merck Co , Bayhelix Group , Wuhan University , Takeda Pharmaceuticals , Prior To Kira Pharmaceuticals , Kellogg School Of Management At Northwestern University , While At Kira Pharmaceuticals , Science Academy , Kira Pharmaceuticals , Abbott Labs , Prnewswire Cargene Biopharma Inc , University Of Illinois At Urbana Champaign , Chief Executive Officer , Yann Chong Tan , Chief Business Officer , General Manager , Corporate Development , Abbisko Therapeutics , Managing Director , Venture Partner , Molecular Biology ,

Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China

Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
News provided by
Share this article
Share this article
CAMBRIDGE, Mass. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders, Kathy He, Richard Lee, MD, and Dana Zhang, MD, to its expanding team. Ms. He joins Kira as Chief Business Officer; Dr. Lee joins as Chief Medical Officer; and Dr. Zhang as Chief Commercial Officer, China, strengthening the executive team at a key time of growth for the company. ....

City Of , United Kingdom , Hong Kong , United States , Frederick Beddingfield , Richard Lee , Dana Zhang , Prnewswire Kira Pharmaceuticals , Head Of Corporate Development At Abbisko Therapeutics , Head Of Hematology At Alexion Pharmaceuticals , Bayer Pharmaceuticals , Alexion Pharmaceuticals , Takeda Pharmaceuticals , Kira Pharmaceuticals , Head Of Business Development For Celgene China , Chief Business Officer , Chief Medical Officer , Chief Commercial Officer , Chief Executive Officer , Corporate Development , Abbisko Therapeutics , General Manager , Greater China , Business Development , Celgene China , Country Manager ,